Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 1
1980 1
1981 1
1982 3
1986 1
1987 1
1988 2
1989 2
1990 1
1992 2
1994 3
1995 2
1997 2
1998 6
1999 1
2000 1
2001 5
2002 4
2003 1
2004 2
2005 5
2006 3
2007 7
2008 4
2009 5
2010 6
2011 8
2012 10
2013 7
2014 6
2015 13
2016 5
2017 7
2018 5
2019 2
2020 4
2021 3
2022 2
2023 7
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic emergencies.
Kwon KT, Tsai VW. Kwon KT, et al. Among authors: tsai vw. Emerg Med Clin North Am. 2007 Nov;25(4):1041-60, vi. doi: 10.1016/j.emc.2007.07.009. Emerg Med Clin North Am. 2007. PMID: 17950135 Review.
GDF15 research from bench to bedside.
Breit SN, Brown DA, Tsai VWW. Breit SN, et al. Among authors: tsai vww. Cancer Cell. 2024 Nov 11;42(11):1823-1824. doi: 10.1016/j.ccell.2024.10.002. Epub 2024 Oct 24. Cancer Cell. 2024. PMID: 39454578
GDF15 analogs as obesity therapeutics.
Breit SN, Brown DA, Tsai VWW. Breit SN, et al. Among authors: tsai vww. Cell Metab. 2023 Feb 7;35(2):227-228. doi: 10.1016/j.cmet.2023.01.002. Cell Metab. 2023. PMID: 36754014 Free article.
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial.
Parsons MW, Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell BCV, Russell ML, Sharma G, Chen C, Lin L, Chew BL, Ng FC, Deepak A, Choi PMC, Kleinig TJ, Cordato DJ, Wu TY, Fink JN, Ma H, Phan TG, Markus HS, Molina CA, Tsai CH, Lee JT, Jeng JS, Strbian D, Meretoja A, Arenillas JF, Buck BH, Devlin MJ, Brown H, Butcher KS, O'Brien B, Sabet A, Wijeratne T, Bivard A, Grimley RS, Agarwal S, Munshi SK, Donnan GA, Davis SM, Miteff F, Spratt NJ, Levi CR; TASTE investigators. Parsons MW, et al. Lancet Neurol. 2024 Aug;23(8):775-786. doi: 10.1016/S1474-4422(24)00206-0. Epub 2024 Jun 13. Lancet Neurol. 2024. PMID: 38880118 Clinical Trial.
152 results